The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation
Open accessAbstract
Objective— The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and Results— LRP-1 −/− macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1 −/− cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 −/− macrophages displayed enhanced inflammation with increased IL-1β, IL-6, and tumor necrosis factor-α expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1 −/− vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1 −/− phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 −/− lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages. Conclusion— Macrophage LRP-1 deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1 −/− macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that apoE-LRP1 interactions in macrophages control the rate of apoE secretion ( 51 ).”
From Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice (2014) · cites this paper as [51]
In the citing paper
“Consistent with the role of defective efferocytosis in contributing to atherosclerosis progression, loss of LRP1 in haematopoietic cells increases atherosclerotic lesion area and necrotic core size in athero-prone mice fed a high-fat diet199,200.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases
Rüegg, U. T., & Gillian, B. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90263-0 · Cited by 904
Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis
Tabas, I. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509
Herz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Research works printed but not linked: 1
- 10.1161/circ.99.19.2571 · DOI
Cited by
Sorted by citations
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationInflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Efferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066
Phagocytosis of apoptotic cells in homeostasis
Arandjelovic, S., & Ravichandran, K. S. (2015) · Nature Immunology · doi:10.1038/ni.3253 · Cited by 959
Monocyte-macrophages and T cells in atherosclerosis
Tabas, I., & Lichtman, A. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.008 · Cited by 646
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
Morioka, S., Maueröder, C., & Ravichandran, K. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.018 · Cited by 391
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300
The role of efferocytosis in atherosclerosis
Kojima, Y., Weissman, I. L., & Leeper, N. J. (2017) · Circulation · doi:10.1161/circulationaha.116.025684 · Cited by 289
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis
Linton, M. F., Babaev, V. R., Huang, J., Linton, E. F., Tao, H., & Yancey, P. G. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0924 · Cited by 235
Self-citationLipoprotein receptor signalling in atherosclerosis
Mineo, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 232
LDL Receptor–Related Protein-1
Gonias, S. L., & Campana, W. M. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.08.029 · Cited by 175
Local effects of human PCSK9 on the atherosclerotic lesion
Giunzioni, I., Tavori, H., Covarrubias, R., Major, A. S., Ding, L., Zhang, Y., DeVay, R. M., Hong, L., Fan, D., Predazzi, I. M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4630 · Cited by 192
Self-citationInflammation Resolution: Implications for Atherosclerosis
Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 181
Efferocytosis in atherosclerosis
Adkar, S. S., & Leeper, N. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01037-7 · Cited by 182
PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages
Schilperoort, M., Ngai, D., Katerelos, M., Power, D. A., & Tabas, I. A. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00736-8 · Cited by 166
The walking dead: macrophage inflammation and death in atherosclerosis
Kavurma, M. M., Rayner, K. J., & Karunakaran, D. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000394 · Cited by 146
Tao, H., Yancey, P. G., Babaev, V. R., Blakemore, J. L., Zhang, Y., Ding, L., Fazio, S., & Linton, M. F. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m056689 · Cited by 143
Self-citationEfferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134
Low-Density Lipoprotein Receptor–Related Protein-1
Strickland, D. K., Au, D. T., Cunfer, P., & Muratoglu, S. C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301924 · Cited by 137
González, L., & Trigatti, B. L. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.12.010 · Cited by 136
The Role of Inflammation in Cardiovascular Outcome
Montecucco, F., Liberale, L., Bonaventura, A., Vecchié, A., Dallegri, F., & Carbone, F. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0646-1 · Cited by 133
Dato, V. A., & Chiabrando, G. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061780 · Cited by 130
Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis
Doddapattar, P., Dev, R., Ghatge, M., Patel, R. B., Jain, M. K., Dhanesha, N., Lentz, S. R., & Chauhan, A. K. (2022) · Circulation Research · doi:10.1161/circresaha.121.320704 · Cited by 126
Luo, Y., Sun, G., Dong, X., Wang, M., Qin, M., Yu, Y., & Sun, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120259 · Cited by 124
Macrophage LRP1 contributes to the clearance of von Willebrand factor
Rastegarlari, G., Pegon, J. N., Casari, C., Odouard, S., Navarrete, A., Saint-Lu, N., van Vlijmen, B. J. M., Legendre, P., Christophe, O. D., Denis, C. V., et al. (2012) · Blood · doi:10.1182/blood-2011-08-373605 · Cited by 124
An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo
Subramanian, M., Hayes, C. D., Thome, J. J. C., Thorp, E. B., Matsushima, G. K., Herz, J., Färber, D. L., Liu, K., Lakshmana, M. K., & Tabas, I. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72051 · Cited by 126
Signaling through LRP1: Protection from atherosclerosis and beyond
Boucher, P., & Herz, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.09.018 · Cited by 122
Yamamoto, S., Yancey, P. G., Zuo, Y., Ma, L.-J., Kaseda, R., Fogo, A. B., Ichikawa, I., Linton, M. F., Fazio, S., & Kon, V. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237198 · Cited by 115
Self-citationThe Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Self-citationThorp, E., Subramanian, M., & Tabas, I. (2011) · European Journal of Immunology · doi:10.1002/eji.201141719 · Cited by 107
Xian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S. X., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 102
Mueller, P. A., Zhu, L., Tavori, H., Huynh, K. T., Giunzioni, I., Stafford, J. M., Linton, M. F., & Fazio, S. (2018) · Circulation · doi:10.1161/circulationaha.117.031702 · Cited by 103
Self-citation2016 Russell Ross Memorial Lecture in Vascular Biology
Tabas, I. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308036 · Cited by 92
Karagiannis, A. D., Liu, M., Toth, P. P., Zhao, S., Agrawal, D. K., Libby, P., & Chatzizisis, Y. S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0718-x · Cited by 93
Atherosclerosis in chronic kidney disease: the role of macrophages
Kon, V., Linton, M. F., & Fazio, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.157 · Cited by 89
Self-citationWang, Y., Liu, X.-Y., Wang, Y., Zhao, W.-X., Li, F.-D., Guo, P.-R., Fan, Q., & Wu, X.-F. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102763 · Cited by 85
Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
Potere, N., Buono, M. G. D., Mauro, A. G., Abbate, A., & Toldo, S. A. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00051 · Cited by 86
Yancey, P. G., Ding, Y., Fan, D., Blakemore, J. L., Zhang, Y., Ding, L., Zhang, J., Linton, M. F., & Fazio, S. (2011) · Circulation · doi:10.1161/circulationaha.111.032268 · Cited by 83
Self-citationYamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq759 · Cited by 74
Self-citationDendritic cells in atherosclerosis
Subramanian, M., & Tabas, I. A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0400-x · Cited by 78
Eating the dead to keep atherosclerosis at bay
Brophy, M. L., Dong, Y., Wu, H., Rahman, H. N. A., Song, K., & Chen, H. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00002 · Cited by 68
Liu, B., Zhang, B., Guo, R., Li, S., & Xu, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1609 · Cited by 68
The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
Chen, J., Su, Y., Pi, S., Hu, B., & Mao, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.682389 · Cited by 70
Brophy, M. L., Dong, Y., Tao, H., Yancey, P. G., Song, K., Zhang, K., Wen, A., Wu, H., Lee, Y., Malovichko, M. V., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313028 · Cited by 65
Self-citationMay, P., Bock, H. H., & Nofer, J. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1699-2 · Cited by 64
Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 67
LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages
Lillis, A. P., Muratoglu, S. C., Au, D. T., Migliorini, M. M., Lee, M., Fried, S. K., MIKHAILENKO, I. A., & Strickland, D. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128903 · Cited by 72
Rosenson, R. S., Hegele, R. A., & Köenig, W. (2019) · Circulation Research · doi:10.1161/circresaha.118.313238 · Cited by 61
Fan, C.-S., Chen, C.-C., Chen, L.-L., Chua, K. V., Hung, H.-C., Hsu, J. T.-A., & Huang, T.-S. (2022) · Cells · doi:10.3390/cells11020229 · Cited by 60
LRP-1: Functions, Signaling and Implications in Kidney and Other Diseases
Lin, L., & Hu, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222887 · Cited by 60
Fan, C.-S., Chen, L.-L., Hsu, T., Chen, C., Chua, K. V., Li, C., & Huang, T. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0826-2 · Cited by 56
Mantuano, E., Henry, K. W., Yamauchi, T., Hiramatsu, N., Yamauchi, K., Orita, S., Takahashi, K., Lin, J. H., Gonias, S. L., & Campana, W. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2850-11.2011 · Cited by 56
LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation
Mao, H., Lockyer, P. P., Townley-Tilson, W. H. D., Xie, L., & Pi, X. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306713 · Cited by 54
Tano, J.-Y., Solanki, S. A., Lee, R. H., Smedlund, K., Birnbaumer, L., & Vázquez, G. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt231 · Cited by 49
Bonacina, F., Martini, E., Svecla, M., Nour, J., Cremonesi, M., Beretta, G., Moregola, A., Pellegatta, F., Zampoleri, V., Catapano, A. L., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa264 · Cited by 49
LRP1: A chameleon receptor of lung inflammation and repair
Wujak, L. A., Schnieder, J., Schaefer, L., & Wygrecka, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.12.007 · Cited by 48
The low-density lipoprotein receptor-related protein 1 in inflammation
May, P. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835e809c · Cited by 49
Zhu, L., Giunzioni, I., Tavori, H., Covarrubias, R., Ding, L., Zhang, Y., Ormseth, M., Major, A. S., Stafford, J. M., Linton, M. F., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307736 · Cited by 46
Self-citationWang, G., Manaenko, A., Shao, A., Ou, Y., Yang, P., Enkhjargal, B., Nowrangi, D., Zhang, J. H., & Tang, J. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654494 · Cited by 45
The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
Ouyang, Z., Zhong, J., Shen, J., & Zeng, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1179828 · Cited by 44
Macrophage/foam cell is an attribute of inflammation: Mechanisms of formation and functional role
Dushkin, M. I. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912040025 · Cited by 48
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
Lin, D., Kang, X., Shen, L. H., Tu, S., Lenahan, C., Chen, Y., Wang, X., & Shao, A. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.04.010 · Cited by 48
Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis
Yurdagul, A. (2021) · Immunometabolism · doi:10.20900/immunometab20210017 · Cited by 41
Costales, P., Castellano, J., Revuelta‐López, E., Cal, R., Aledo, R., Llampayas, O., Nasarre, L., Juárez, C., Badimón, L., & Llorente‐Cortés, V. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.021 · Cited by 42
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Yamamoto, S., Zhong, J., Yancey, P. G., Zuo, Y., Linton, M. F., Fazio, S., Yang, H., Narita, I., & Kon, V. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.055 · Cited by 40
Self-citationDhawan, U. K., Singhal, A., & Subramanian, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105699 · Cited by 41
LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes
Hamlin, A. N., Basford, J. E., Jaeschke, A., & Hui, D. Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.717744 · Cited by 39
Mueller, P. A., Kojima, Y., Huynh, K. T., Maldonado, R. A., Ye, J., Tavori, H., Pamir, N., Leeper, N. J., & Fazio, S. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316854 · Cited by 40
Self-citationXie, Y., Chen, H., Qu, P., Qiao, X., Guo, L., & Liu, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109260 · Cited by 40
Multi-faceted role of LRP1 in the immune system
Sizova, O. S., John, L. S. S., Ma, Q., & Molldrem, J. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166189 · Cited by 40
Wohner, N., Legendre, P., Casari, C., Christophe, O. D., Lenting, P. J., & Denis, C. V. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12885 · Cited by 38
Impairment of survival signaling and efferocytosis in TRPC3-deficient macrophages
Tano, J.-Y., Smedlund, K., Lee, R., Abramowitz, J., Birnbaumer, L., & Vázquez, G. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.045 · Cited by 37
Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction
Potere, N., Buono, M. G. D., Niccoli, G., Crea, F., Toldo, S. A., & Abbate, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030544 · Cited by 36
Au, D. T., Migliorini, M. M., Strickland, D. K., & Muratoglu, S. C. (2018) · Mediators of Inflammation · doi:10.1155/2018/7902841 · Cited by 36
Solanki, S., Dube, P. R., Birnbaumer, L., & Vázquez, G. (2017) · Scientific Reports · doi:10.1038/srep42526 · Cited by 35
Mallat, Z. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304794 · Cited by 34
Gordts, P. L. S. M., Bartelt, A., Nilsson, S. K., Annaert, W. G., Christoffersen, C., Nielsen, L. B., Heeren, J., & Roebroek, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038330 · Cited by 33
Bornachea, O., Benitez‐Amaro, A., Vea, À., Nasarre, L., de Gonzalo‐Calvo, D., Escolá‐Gil, J. C., Cedó, L., Iborra, A., Martínez‐Martínez, L., Juárez, C., et al. (2020) · Theranostics · doi:10.7150/thno.37305 · Cited by 31
García-Fernández, P., Üçeyler, N., & Sommer, C. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000898 · Cited by 32
Thorp, E. B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00039 · Cited by 31
Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling
Tano, J.-Y., & Vázquez, G. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.048 · Cited by 27
Bouchareychas, L., Pirault, J., Saint-Charles, F., Deswaerte, V., Roy, T. L., Jessup, W., Giral, P., Goff, W. L., Huby, T., Gautier, E. L., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv177 · Cited by 26
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease
Zhang, B., Zou, Y., Yuan, Z., Jiang, K., Zhang, Z., Chen, S., Zhou, X., Wu, Q., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1485222 · Cited by 30
Wang, Y., Zhang, W., Xu, Y., Wu, D., Gao, Z., Zhou, J., Qian, H., He, B., & Wang, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.767630 · Cited by 27
Efferocytosis in dendritic cells: an overlooked immunoregulatory process
Ma, Y., Jiang, T., Zhu, X., Xu, Y., Wan, K., Zhang, T., & Xie, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1415573 · Cited by 24
The Pivotal Role of Thymus in Atherosclerosis Mediated by Immune and Inflammatory Response
Dai, X., Zhang, D., Wang, C., Wu, Z., & Liang, C. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27238 · Cited by 23
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
Lam, A. L., & Heit, B. (2021) · Cells · doi:10.3390/cells10051265 · Cited by 22
Functional Rescue of P23H Rhodopsin Photoreceptors by Gene Delivery
Gorbatyuk, M. S., Gorbatyuk, O. S., LaVail, M. M., Lin, J. H., Hauswirth, W. W., & Lewin, A. S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_26 · Cited by 24
Revuelta‐López, E., Cal, R., Herraiz‐Martínez, A., de Gonzalo‐Calvo, D., Nasarre, L., Roura, S., Gálvez‐Montón, C., Bayés‐Genís, A., Badimón, L., Hove‐Madsen, L., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.028 · Cited by 23
Efferocytosis: the art of cellular clearance and novel perspectives in disease therapy
Li, G., Xu, J., Tian, X., Xiao, J., Long, J., Chen, Y., Shen, W., & Zhao, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02484-7 · Cited by 29
Immune system and atherosclerosis: Hostile or friendly relationship
Razeghian‐Jahromi, I., Akhormeh, A. K., Razmkhah, M., & Zibaeenezhad, M. J. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221092188 · Cited by 22
Pattern Recognition Proteins: First Line of Defense Against Coronaviruses
Labarrere, C. A., & Kassab, G. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652252 · Cited by 22
Macrophage efferocytosis in atherosclerosis
Baraniecki, Ł., Tokarz–Deptuła, B., Syrenicz, A., & Deptuła, W. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13251 · Cited by 21
Jarr, K.-U., Kojima, Y., Weissman, I. L., & Leeper, N. J. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317049 · Cited by 21
Chinnarasu, S., Alogaili, F., Bove, K. E., Jaeschke, A., & Hui, D. Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100370 · Cited by 19
Metabolic reprogramming in efferocytosis
Yan, Q., Li, K., Chen, L., Wang, A., Xi, Y., Xiao, H., & Yuan, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1677028 · Cited by 19
Metadata
- Authors
- Yancey, P. G., Blakemore, J., Ding, L., Fan, D., Overton, C. D., Zhang, Y., Linton, M. F., & Fazio, S.
- Affiliations
- Vanderbilt University Medical Center (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2010-04
- Volume
- 30
- Issue
- 4
- Pages
- 787-795
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- PMC
- PMC2845445
- OpenAlex
- W2108626579
- Cited by
- 168
- References
- 59
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 8 · 2023: 12 · 2022: 15 · 2021: 12 · 2020: 7 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 14 · 2014: 6 · 2013: 8 · 2012: 10
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL057986, R01HL065709, HL57986, R01HL086988, HL 53989, R01HL065405, HL 65405, R01HL053989, HL65709)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59637, U24DK059637)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- LRP1, apolipoprotein E, efferocytosis, macrophage apoptosis, Akt signaling, atherosclerosis, plaque inflammation, necrotic core, macrophage phagocytosis, oxidized LDL, lipopolysaccharide, caspase-3, Bad phosphorylation
- MeSH terms
- Animals, Apolipoproteins E, Cell Survival, Cells, Cultured, Enzyme Activation, Female, Inflammation, Lipopolysaccharides, Lipoproteins, LDL, Necrosis, Phagocytosis, Phosphorylation, Receptors, LDL, Tumor Necrosis Factor-alpha, Interleukin-6, Apoptosis, Macrophages, Peritoneal, Mice, Knockout, In Situ Nick-End Labeling, Tumor Suppressor Proteins, Low Density Lipoprotein Receptor-Related Protein-1, Atherosclerosis, Proto-Oncogene Proteins c-akt, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
